Home > Insider Trading > Filing (0001102624-12-000285)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1261734	Aeolus Pharmaceuticals Inc.	AOLS	Pharmaceutical Preparations (2834)	561953785

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1296750	J Joseph Krivulka	C/O Aeolus Pharmaceuticals, Inc. 26361 Crown Valley Parkway, Suite 150 Mission Viejo CA 92691		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.01 Par Value Per Share	Acquisiton	2012-04-05	333,333	$0.30	333,333	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrants (right to buy)	Acquisiton	2012-04-05	250,000	$0.30	250,000	$0.40

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
250,000	2012-04-05	2017-04-05	No	4	P	Direct

Footnotes

Pursuant to a Securities Purchase Agreement by and between Aeolus Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and Mr. Krivulka, dated as of April 5, 2012, the Company issued and sold 333,333 Units (the "Units") to Mr. Krivulka for a total purchase price of $99,999.90, or $0.30 per Unit. Each Unit is comprised of one (1) share of the Company's common stock, $0.01 par value per share (the "Common Stock"), and one (1) warrant to purchase .75 of one (1) share of Common Stock with an initial exercise price of $0.40 per share of Common Stock, subject to certain adjustments.